(VIANEWS) – Shares of Sorrento Therapeutics (NASDAQ: SRNE) dropped 5.39% to $3.60 at 15:34 EST on Tuesday, after three consecutive sessions in a row of losses. NASDAQ is jumping 0.63% to $13,855.10, following the last session’s upward trend. This seems, up to now, a somewhat positive trend exchanging session today.
Sorrento Therapeutics’s last close was $3.54, 79.51% under its 52-week high of $17.25.
Today’s last reported volume for Sorrento Therapeutics is 6282444 which is 7.43% above its average volume of 5847456.
Sorrento Therapeutics’s Sales
Sorrento Therapeutics’s sales growth is a negative 13.4% for the current quarter and 13% for the next. The company’s growth estimates for the ongoing quarter and the next is 30.3% and 14.8%, respectively.
Sorrento Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 84.6%, now sitting on 46.52M for the twelve trailing months.
Sorrento Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.71%, a negative 1.41%, and a positive 3.52%, respectively.
Sorrento Therapeutics’s highest amplitude of average volatility was 5.66% (last week), 4.12% (last month), and 3.52% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Sorrento Therapeutics’s stock is considered to be overbought (>=80).
Sorrento Therapeutics’s Stock Yearly Top and Bottom Value
Sorrento Therapeutics’s stock is valued at $3.60 at 15:34 EST, way under its 52-week low of $4.69.
Sorrento Therapeutics’s Moving Average
Sorrento Therapeutics’s worth is way under its 50-day moving average of $6.36 and way under its 200-day moving average of $7.85.
More news about Sorrento Therapeutics (SRNE).